John M. Sharretts

Cancer Risk Associated with Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial

John M. Sharretts, Ovidiu Galescu, Shanti Gomatam et al. · New England Journal of Medicine · 2020 · 140 citations

Conversion from Intravenous Insulin to Subcutaneous Insulin After Cardiovascular Surgery: Transition to Target Study

Mansur Shomali, Daniel Herr, Peter C. Hill et al. · Diabetes Technology & Therapeutics · 2011 · 29 citations

Synergy to Reduce Emergency Department Visits for Uncontrolled Hyperglycemia

Michelle Magee, Carine M. Nassar, James Copeland et al. · The Diabetes Educator · 2013 · 17 citations

Should responder analyses be conducted on continuous outcomes?

Robert Abugov, Jennifer Clark, Laura Higginbotham et al. · Pharmaceutical Statistics · 2022 · 15 citations

Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1

Sakshi Jhawar, Rahul Lakhotia, Mari Suzuki et al. · Endocrinology Diabetes and Metabolism Case Reports · 2019 · 13 citations · Full text